Published in BMC Gastroenterol on January 22, 2014
The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol (2006) 12.80
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res (1998) 2.58
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther (2004) 2.13
Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol (2005) 1.87
Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol (2006) 1.64
The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res (2005) 1.59
The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther (2007) 1.53
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut (2010) 1.44
The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes (2008) 1.18
Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol (2009) 1.13
Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil (2010) 1.10
Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.07
Assessment of reflux symptom severity: methodological options and their attributes. Gut (2004) 1.00
Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enferm Dig (2002) 0.95
[Psychometric validation of translation to Spanish of the gastrointestinal symptoms rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) in patients with gastroesophageal reflux disease]. Rev Clin Esp (2005) 0.92
Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther (2006) 0.91
Gastroesophageal Reflux Disease Questionnaire (GerdQ) in real-world practice: a national multicenter survey on 8065 patients. J Gastroenterol Hepatol (2013) 0.90
Prevalence of gastro-oesophageal reflux disease in Spain and associated factors. Aliment Pharmacol Ther (2006) 0.90
Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire. J Neurogastroenterol Motil (2013) 0.87
Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease? Aliment Pharmacol Ther (2004) 0.87
Occurrence of nighttime gastroesophageal reflux in disturbed and normal sleepers. Clin Gastroenterol Hepatol (2008) 0.85
A population-based survey to assess troublesome symptoms in gastroesophageal reflux disease. Scand J Gastroenterol (2009) 0.83
Approach to gastroesophageal reflux disease in primary care: Putting the Montreal definition into practice. Can Fam Physician (2008) 0.83
[Validation of the Reflux Disease Questionnaire (RDQ) and Gastrointestinal Impact Scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population]. Gastroenterol Hepatol (2009) 0.81
Performance of the Montreal Consensus in the diagnosis of gastroesophageal reflux disease in morbidly obese patients. Obes Surg (2008) 0.79
[Clinical practice guideline on the management of patients with gastroesophageal reflux disease (GERD)]. Gastroenterol Hepatol (2002) 0.78
Medical consultation for gastro-oesophageal reflux symptoms: reasons and associated factors. Digestion (2004) 0.78
Perceptions and beliefs concerning gastroesophageal reflux disease: physicians and patients disagree. Digestion (2007) 0.77
[Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Med Clin (Barc) (2005) 2.90
MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis (2006) 1.54
Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med (2011) 1.48
A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol (2009) 1.47
Translation, cultural adaptation and validation of a Spanish version of the Irritable Bowel Syndrome Severity Score. Rev Esp Enferm Dig (2011) 1.38
Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci (2002) 1.21
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol (2003) 1.20
Internet option in a mail survey: more harm than good? Epidemiology (2010) 1.12
New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses. AIDS Res Hum Retroviruses (2007) 1.10
Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. PLoS One (2012) 1.09
Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol (2009) 1.06
Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis (2006) 1.06
The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF. Infect Genet Evol (2004) 1.04
Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics (2006) 1.02
Shortening a survey and using alternative forms of prenotification: impact on response rate and quality. BMC Med Res Methodol (2010) 1.01
CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One (2010) 1.01
Role of the PXR gene locus in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 1.00
Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol (2006) 0.98
Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol (2012) 0.98
Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes (2009) 0.98
Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients. Am J Gastroenterol (2012) 0.96
Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2012) 0.96
Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet (2006) 0.96
Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur J Hum Genet (2009) 0.96
Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol (2004) 0.95
Molecular epidemiology of HIV-1 in St Petersburg, Russia: predominance of subtype A, former Soviet Union variant, and identification of intrasubtype subclusters. J Acquir Immune Defic Syndr (2009) 0.94
Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics (2007) 0.93
IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis (2008) 0.93
High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol (2010) 0.93
Impact of gastroesophageal reflux disease on the quality of life of Spanish patients: the relevance of the biometric factors and the severity of symptoms. Eur J Gastroenterol Hepatol (2009) 0.92
Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol (2009) 0.92
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics (2002) 0.92
Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data. J Gastroenterol Hepatol (2012) 0.91
Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: a Study in the Spanish population and a meta-analysis. Inflamm Bowel Dis (2009) 0.89
High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance. Antivir Ther (2003) 0.87
Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1. J Clin Microbiol (2005) 0.86
Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology (2012) 0.86
Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity. Dig Dis Sci (2008) 0.86
Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain. J Med Virol (2006) 0.85
Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress. Clin Gastroenterol Hepatol (2008) 0.84
Control of persistent asthma in Spain: associated factors. J Asthma (2008) 0.83
Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol (2006) 0.83
Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases. BMC Genomics (2008) 0.83
Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver Int (2005) 0.82
Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population. Eur J Cancer (2005) 0.82
Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease. Scand J Gastroenterol (2005) 0.82
Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: the INCA study. Qual Life Res (2008) 0.82
[Validation of the Reflux Disease Questionnaire (RDQ) and Gastrointestinal Impact Scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population]. Gastroenterol Hepatol (2009) 0.81
Analysis of the REL polymorphism rs13031237 in autoimmune diseases. Ann Rheum Dis (2010) 0.81
Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis. Hum Immunol (2010) 0.81
GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic. J Infect Dis (2007) 0.80
Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications. World J Gastroenterol (2009) 0.80
The burden and management of patients with IBS: Results from a survey in spanish gastroenterologists. Rev Esp Enferm Dig (2011) 0.80
[Symptom profile in gastroesophageal reflux disease in untreated patients and those with persistent symptoms despite treatment]. Gastroenterol Hepatol (2010) 0.79
Validation of a questionnaire for assessing fecal impaction in the elderly: impact of cognitive impairment, and using a proxy. BMC Geriatr (2013) 0.78
Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients. Hum Immunol (2006) 0.78
[Utility of liver biopsy in the etiologic diagnosis of biochemical liver abnormalities of unknown cause]. Gastroenterol Hepatol (2007) 0.78
Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods. Scand J Gastroenterol (2010) 0.78
Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study. Eur J Gastroenterol Hepatol (2009) 0.78
A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain. J Asthma (2011) 0.78
Advantages of early cholecystectomy in clinical practice of a terciary care center. Hepatobiliary Pancreat Dis Int (2013) 0.77
[Quality of life specific questionnaire for constipated patients: development and validation of CVE-20]. Med Clin (Barc) (2008) 0.77
Glutathione S-transferases pi 1, alpha 1 and M3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans. Pharmacogenomics (2007) 0.77
MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease. Inflamm Bowel Dis (2007) 0.77
Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease. J Crohns Colitis (2011) 0.76
A recombined haplotype in the major histocompatibility region contains a cluster of genes conferring high susceptibility to ulcerative colitis in the Spanish population. Inflamm Bowel Dis (2005) 0.76
Strong protective effect of DR3 against ulcerative colitis in the Spanish population. Am J Gastroenterol (2007) 0.76
Polymorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn's disease. World J Gastroenterol (2006) 0.76
Probiotics for irritable bowel syndrome: should we give them full names? Rev Esp Enferm Dig (2013) 0.76
Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists. World J Gastroenterol (2012) 0.75
The irritable bowel syndrome care process from the patients´ and professionals´ views. Rev Esp Enferm Dig (2015) 0.75
[Functional and motility gastrointestinal disorders]. Gastroenterol Hepatol (2012) 0.75
[Extraesophageal manifestations of reflux disease]. Med Clin (Barc) (2006) 0.75
[Therapeutic update in hepatitis C]. Rev Esp Quimioter (2015) 0.75
Impact of Personal Protective Equipment on Surgical Performance During the COVID-19 Pandemic. World J Surg (2020) 0.75
"12 weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: two prognostic categories under the same label? Scand J Gastroenterol (2008) 0.75
[Study of the clinical profile and management of patients with gastroesophageal reflux disease in primary care in Spain]. Gastroenterol Hepatol (2010) 0.75
[Use of health resources and loss of productivity in gastroesophageal reflux disease: results of a cross-sectional study in a primary care setting in Spain]. Aten Primaria (2011) 0.75
A computer-assisted morphometric quantitative analysis of iron overload in liver biopsies. A comparison with histological and biochemical methods. Pathol Res Pract (2005) 0.75
[Functional and motor digestive disorders]. Gastroenterol Hepatol (2013) 0.75
[Functional and motility gastrointestinal disorders]. Gastroenterol Hepatol (2011) 0.75
Weight Gain and Somatization are Associated With the Onset of Gastroesophageal Reflux Diseases: Results of Two 5-year Follow-up Studies. J Clin Gastroenterol (2016) 0.75
Conclusions of the II International and IV Spanish Hydration Congress. Toledo, Spain, 2nd-4th December, 2015. Nutr Hosp (2016) 0.75
Prevalence and persistence of nausea and vomiting along the pregnancy. Rev Esp Enferm Dig (2014) 0.75
Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease. Scand J Gastroenterol (2009) 0.75
Endothelin A (ET(A)) receptors are involved in augmented adrenergic vasoconstriction and blunted nitric oxide-mediated relaxation of penile arteries from insulin-resistant obese zucker rats. J Sex Med (2014) 0.75